Medical - Devices
Compare Stocks
2 / 10Stock Comparison
ATEC vs NUVL
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
ATEC vs NUVL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Biotechnology |
| Market Cap | $1.06B | $6.92B |
| Revenue (TTM) | $595M | $0.00 |
| Net Income (TTM) | $-125M | $-381M |
| Gross Margin | 89.6% | — |
| Operating Margin | -9.6% | — |
| Forward P/E | 24.4x | — |
| Total Debt | $620M | $0.00 |
| Cash & Equiv. | $161M | $146M |
ATEC vs NUVL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 21 | May 26 | Return |
|---|---|---|---|
| Alphatec Holdings, … (ATEC) | 100 | 47.4 | -52.6% |
| Nuvalent, Inc. (NUVL) | 100 | 571.3 | +471.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ATEC vs NUVL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ATEC is the clearest fit if your priority is growth exposure.
- Rev growth 25.0%, EPS growth 15.0%, 3Y rev CAGR 29.6%
- -15.8% ROA vs NUVL's -38.9%, ROIC -12.6% vs -32.6%
NUVL carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 1.09
- 456.1% 10Y total return vs ATEC's 172.8%
- Lower volatility, beta 1.09, current ratio 20.96x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 38.2% revenue growth vs ATEC's 25.0% | |
| Quality / Margins | 3.4% margin vs ATEC's -21.1% | |
| Stability / Safety | Beta 1.09 vs ATEC's 1.13 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +52.9% vs ATEC's -42.6% | |
| Efficiency (ROA) | -15.8% ROA vs NUVL's -38.9%, ROIC -12.6% vs -32.6% |
ATEC vs NUVL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ATEC vs NUVL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ATEC leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
ATEC and NUVL operate at a comparable scale, with $595M and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $595M | $0 |
| EBITDAEarnings before interest/tax | $4M | -$408M |
| Net IncomeAfter-tax profit | -$125M | -$381M |
| Free Cash FlowCash after capex | $7M | -$264M |
| Gross MarginGross profit ÷ Revenue | +89.6% | — |
| Operating MarginEBIT ÷ Revenue | -9.6% | — |
| Net MarginNet income ÷ Revenue | -21.1% | — |
| FCF MarginFCF ÷ Revenue | +1.2% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | -100.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +37.1% | -32.8% |
Valuation Metrics
NUVL leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.1B | $6.9B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $6.8B |
| Trailing P/EPrice ÷ TTM EPS | -7.28x | -26.53x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.43x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 3487.65x | — |
| Price / SalesMarket cap ÷ Revenue | 1.38x | — |
| Price / BookPrice ÷ Book value/share | 29.11x | 6.47x |
| Price / FCFMarket cap ÷ FCF | 381.12x | — |
Profitability & Efficiency
ATEC leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
NUVL delivers a -45.1% return on equity — every $100 of shareholder capital generates $-45 in annual profit, vs $-142 for ATEC. On the Piotroski fundamental quality scale (0–9), ATEC scores 6/9 vs NUVL's 1/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -141.9% | -45.1% |
| ROA (TTM)Return on assets | -15.8% | -38.9% |
| ROICReturn on invested capital | -12.6% | -32.6% |
| ROCEReturn on capital employed | -13.7% | -31.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 1 |
| Debt / EquityFinancial leverage | 17.21x | — |
| Net DebtTotal debt minus cash | $459M | -$146M |
| Cash & Equiv.Liquid assets | $161M | $146M |
| Total DebtShort + long-term debt | $620M | $0 |
| Interest CoverageEBIT ÷ Interest expense | -2.40x | — |
Total Returns (Dividends Reinvested)
NUVL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NUVL five years ago would be worth $55,605 today (with dividends reinvested), compared to $4,575 for ATEC. Over the past 12 months, NUVL leads with a +52.9% total return vs ATEC's -42.6%. The 3-year compound annual growth rate (CAGR) favors NUVL at 40.3% vs ATEC's -22.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -66.3% | +3.4% |
| 1-Year ReturnPast 12 months | -42.6% | +52.9% |
| 3-Year ReturnCumulative with dividends | -52.9% | +176.1% |
| 5-Year ReturnCumulative with dividends | -54.3% | +456.1% |
| 10-Year ReturnCumulative with dividends | +172.8% | +456.1% |
| CAGR (3Y)Annualised 3-year return | -22.2% | +40.3% |
Risk & Volatility
NUVL leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NUVL is the less volatile stock with a 1.09 beta — it tends to amplify market swings less than ATEC's 1.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NUVL currently trades 92.3% from its 52-week high vs ATEC's 30.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.13x | 1.09x |
| 52-Week HighHighest price in past year | $23.29 | $113.02 |
| 52-Week LowLowest price in past year | $6.85 | $63.56 |
| % of 52W HighCurrent price vs 52-week peak | +30.0% | +92.3% |
| RSI (14)Momentum oscillator 0–100 | 44.0 | 46.9 |
| Avg Volume (50D)Average daily shares traded | 2.9M | 539K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates ATEC as "Buy" and NUVL as "Buy". Consensus price targets imply 257.7% upside for ATEC (target: $25) vs 38.5% for NUVL (target: $144).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $25.00 | $144.40 |
| # AnalystsCovering analysts | 16 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
NUVL leads in 3 of 6 categories (Valuation Metrics, Total Returns). ATEC leads in 2 (Income & Cash Flow, Profitability & Efficiency).
ATEC vs NUVL: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ATEC or NUVL a better buy right now?
Analysts rate Alphatec Holdings, Inc.
(ATEC) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ATEC or NUVL?
Over the past 5 years, Nuvalent, Inc.
(NUVL) delivered a total return of +456. 1%, compared to -54. 3% for Alphatec Holdings, Inc. (ATEC). Over 10 years, the gap is even starker: NUVL returned +456. 1% versus ATEC's +172. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ATEC or NUVL?
By beta (market sensitivity over 5 years), Nuvalent, Inc.
(NUVL) is the lower-risk stock at 1. 09β versus Alphatec Holdings, Inc. 's 1. 13β — meaning ATEC is approximately 3% more volatile than NUVL relative to the S&P 500.
04Which is growing faster — ATEC or NUVL?
On earnings-per-share growth, the picture is similar: Alphatec Holdings, Inc.
grew EPS 15. 0% year-over-year, compared to -81. 1% for Nuvalent, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ATEC or NUVL?
Nuvalent, Inc.
(NUVL) is the more profitable company, earning 0. 0% net margin versus -18. 8% for Alphatec Holdings, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NUVL leads at 0. 0% versus -10. 7% for ATEC. At the gross margin level — before operating expenses — ATEC leads at 69. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is ATEC or NUVL more undervalued right now?
Analyst consensus price targets imply the most upside for ATEC: 257.
7% to $25. 00.
07Which pays a better dividend — ATEC or NUVL?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
08Is ATEC or NUVL better for a retirement portfolio?
For long-horizon retirement investors, Nuvalent, Inc.
(NUVL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 09), +456. 1% 10Y return). Both have compounded well over 10 years (NUVL: +456. 1%, ATEC: +172. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ATEC and NUVL?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ATEC is a small-cap high-growth stock; NUVL is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.